| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allovir, Inc. | Director, 10%+ Owner | Common Stock | 4,193,874 | $2,813,251 | $0.6708 | 28 Jul 2022 | By F2 Capital I 2020 LLC |
| Allovir, Inc. | Director, 10%+ Owner | Common Stock | 2,059,884 | $1,381,770 | $0.6708 | 28 Jul 2022 | Direct |
| Allovir, Inc. | Director, 10%+ Owner | Common Stock | 2,038,583 | $1,367,481 | $0.6708 | 28 Jul 2022 | By F2 MC, LLC |
| Allovir, Inc. | Director, 10%+ Owner | Common Stock | 867,678 | $582,038 | $0.6708 | 28 Jul 2022 | By F2 Bioscience AV 2022 LLC |
| Allovir, Inc. | Director, 10%+ Owner | Common Stock | 668,072 | $448,143 | $0.6708 | 28 Jul 2022 | By F2-TPO Investments, LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KLRS | Allovir, Inc. | 28 Jul 2022 | 0 | $0 | 3 | Director, 10%+ Owner | 05 Aug 2022, 16:15 |